R. Belostotsky

发表

Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment

R. Belostotsky, Y. Frishberg, 2022, International journal of molecular sciences.

Mutations in DHDPSL are responsible for primary hyperoxaluria type III.

C. Charon, D. Magen, R. Belostotsky, 2010, American journal of human genetics.

Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.

R. Belostotsky, Y. Frishberg, O. Elpeleg, 2011, American journal of human genetics.

Mutations in HOGA1 do Not Confer a Dominant Phenotype Manifesting as Kidney Stone Disease.

M. Duvdevani, G. Curhan, R. Belostotsky, 2020, The Journal of urology.

Human mitochondrial tRNA quality control in health and disease

R. Belostotsky, Y. Frishberg, N. Entelis, 2012, RNA biology.

Apoptosis-Inducing Human-Origin Fcε-Bak Chimeric Proteins for Targeted Elimination of Mast Cells and Basophils: A New Approach for Allergy Treatment1

R. Belostotsky, H. Lorberboum-Galski, 2001, The Journal of Immunology.

Approach for Allergy Treatment of Mast Cells and Basophils : A New Chimeric Proteins for Targeted Elimination-Bak ε Apoptosis-Inducing Human-Origin Fc

R. Belostotsky, H. Lorberboum-Galski, 2001 .

Targeted Fc2′‐3‐PE40 chimeric protein abolishes passive cutaneous anaphylaxis in mice

R. Belostotsky, D. Prus, H. Lorberboum-Galski, 2000, Clinical and experimental immunology.

Linker-based GnRH-PE chimeric proteins inhibit cancer growth in nude mice

R. Belostotsky, A. Ben-Yehudah, A. Nechushtan, 1999, Medical oncology.

Utilizing chimeric proteins for exploring the cellular fate of endogenous proteins.

R. Aqeilan, R. Belostotsky, A. Ben-Yehudah, 2002, Biochemical and biophysical research communications.

Utilizing Fcε-Bak chimeric protein for studying IgE–FcεRI interactions

R. Belostotsky, H. Lorberboum-Galski, 2004 .

A piggybacking mechanism enables peroxisomal localization of the glyoxylate cycle enzyme Mdh2 in yeast

M. Eisenstein, M. Schuldiner, E. Zalckvar, 2020, Journal of Cell Science.

Dent’s disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg?

R. Belostotsky, Y. Frishberg, D. Dinour, 2009, Pediatric Nephrology.

Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications.

J. Melki, J. Sosna, R. Belostotsky, 2009, American journal of human genetics.

Novel therapeutic approaches for the primary hyperoxalurias

R. Belostotsky, Y. Frishberg, 2020, Pediatric Nephrology.

Primary hyperoxaluria type III—a model for studying perturbations in glyoxylate metabolism

R. Belostotsky, Y. Frishberg, J. Pitt, 2012, Journal of Molecular Medicine.

Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.

W. Haley, R. Belostotsky, Y. Frishberg, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria

R. Belostotsky, Y. Frishberg, B. Hoppe, 2018, Journal of Molecular Medicine.

Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria

R. Belostotsky, Y. Frishberg, R. Lyakhovetsky, 2014, Journal of Medical Genetics.

Primary hyperoxaluria type III—a model for studying perturbations in glyoxylate metabolism

R. Belostotsky, Y. Frishberg, J. Pitt, 2012, Journal of Molecular Medicine.

Congenital analbuminemia with acute glomerulonephritis: a diagnostic challenge

R. Belostotsky, Y. Frishberg, S. Feinstein, 2009, Pediatric Nephrology.

Association of post-transplantation anellovirus viral load with kidney transplant rejection in children

R. Belostotsky, Y. Frishberg, Y. Schlesinger, 2022, Pediatric Nephrology.

Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria

R. Belostotsky, Y. Frishberg, B. Hoppe, 2018, Journal of Molecular Medicine.

Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma.

R. Belostotsky, A. Ben-Yehudah, M. Lichtenstein, 2005, International Journal of Oncology.

4-hydroxyglutamate is a biomarker for primary hyperoxaluria type 3.

R. Belostotsky, Y. Frishberg, J. Pitt, 2015, JIMD reports.

Metabolite diagnosis of primary hyperoxaluria type 3

R. Belostotsky, Y. Frishberg, J. Pitt, 2018, Pediatric nephrology (Berlin, West).

A piggybacking mechanism enables peroxisomal localization of the glyoxylate cycle enzyme Mdh2 in yeast.

M. Eisenstein, M. Schuldiner, E. Zalckvar, 2020, Journal of cell science.